11 Best Cosmetic Surgery and Aesthetics Stocks to Invest in Now

7. InMode Ltd. (NASDAQ:INMD)

Number of Hedge Fund Investors: 18

InMode Ltd. (NASDAQ:INMD) is a US-based company that offers minimally invasive surgical aesthetic and medical treatments. Being one of the Best Aesthetics Stocks, its products and solutions focus on three energy-based treatment categories: face and body contouring, medical aesthetics, and women’s health.

InMode Ltd. (NASDAQ:INMD) has created solutions for ophthalmology, gynecology, dermatology, and plastic surgery utilizing their technology. Its product platforms include Morpheus8, EmbraceRF, EvolveX, Evoke, EmpowerRF, Optimas, Votiva, Contoura, Triton, and BodyTite. The United States accounts for the majority of company revenue.

Revenue increased by 6% YoY in Q3 2024 due to fulfilling $31.9 million in pre-orders from the first half of 2024, which offset slower demand for consumables and new platform sales. The cash grew by 1.34% YoY.

On 17 October 2024, BTIG began covering InMode Ltd. (NASDAQ:INMD) with a $25 price target and a Buy rating. In a research note, the analyst informs investors that InMode is a top worldwide supplier of energy-based medical technology utilized for minimally invasive surgical aesthetic procedures. According to the firm, the demand for aesthetic capital procedures and equipment has decreased in recent quarters, causing the stock to trade at four-year lows. However, as the macroeconomic climate stabilizes, BTIG sees several ways the company can resume growth. The firm argues that the risk/reward combination from this point is appealing because the stock is priced at eight times the 2025 profit expectations.

Pedro Escudero’s Doma Perpetual Capital Management was the largest stakeholder in the company among the funds in Insider Monkey’s database. It owns more than 2.2 million shares worth $37.96 million as of Q3.